• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research toward the development of stem cell transplantation augmented graft-versus-tumor effect against childhood malignancies

Research Project

Project/Area Number 21591351
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionKanazawa University

Principal Investigator

NISHIMURA Ryosei  金沢大学, 附属病院, 講師 (50324116)

Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Keywords骨髄移植 / 移植片対宿主病 / IL-17 / Cytokine-induced killer細胞 / 造血幹細胞移植 / GVHD / GVT / CIK
Research Abstract

Cytokine-induced killer(CIK) cells exert strong graft-versus tumor effect(GVT) without causing severe acute graft-versus-host disease(GVHD) in a murine model. However, in some cases CIK cells causes mild chronic GVHD. To reduce chronic GVHD, we studied the role of IL-17, which are involved in the pathogenesis of chronic inflammation, in a murine model. We demonstrated that the mice receiving bone marrow cells from IL-17 knockout mice showed very mild chronic GVHD compared to the mice receiving wild type bone marrow cells. Bone marrow transplantation augmented GVT without causing chronic GVHD might be possible by controlling IL-17.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (15 results)

All 2011 2010 2009

All Presentation (15 results)

  • [Presentation] Both tissue-derived and bone marrow-derived host IL-17 producing cells are required for preventing acute graft-versus-host disease2011

    • Author(s)
      Kuroda R, Nishimura R
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Attem pting to classify prolonged graft-versus-host disease according to monocyte activa tion status in addition to T-cell2011

    • Author(s)
      Kuroda R, Nishimura R, et al
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Only dendritic cells, but not lymphocytes, acquired tolerogenicity by PUVA-treatment by upregulation of indoleamine 2, 3-dioxygenase(IDO)2011

    • Author(s)
      Maeba H, Nishimura R
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Both tissue-derived and bone marrow-derived host IL-17 producing cell are required for preventing acute graft-versus-host disease2011

    • Author(s)
      Kuroda R, Nishimura R, et al
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Annual Research Report
  • [Presentation] Attempting to classify prolonged graft-versus-host disease according to monocyte activation status in addition to T-cell2011

    • Author(s)
      Kuroda R, Nishimura R, et al
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Annual Research Report
  • [Presentation] Only dendritic cells, but not lymphocytes, acquired tolcrogenicity by PUVA-treatment by upregulation of indoleamine 2,3-dioxygenase (IDO)2011

    • Author(s)
      Maeba H, Nishimura R, et al
    • Organizer
      第53回米国血液学会
    • Place of Presentation
      San Diego convention center(米国)
    • Related Report
      2011 Annual Research Report
  • [Presentation] Role of Il-17 varies at different periods after hematopoietic stem cell transplantation : protection from acute graft-versus-host disease and exacerbation of chronic graft-versushost disease2010

    • Author(s)
      Kuroda R, Nishimura R
    • Organizer
      第52回米国血液学会
    • Place of Presentation
      Orange country conventioncenter(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Cytokine-induced killer cells facilitate immune reconstitution after allogeneic BMT in mice2010

    • Author(s)
      Mase S, Nishimura R
    • Organizer
      第52回米国血液学会
    • Place of Presentation
      Orange country convention center(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Potent strategy for treatment of GVHD and a utoimmune disease by infusion of donort-ypedor even third-party tolerogenic de ntritic cells by psoralen plus UVA trea tment2010

    • Author(s)
      Maeba H, Nishimura R
    • Organizer
      第52回米国血液学会
    • Place of Presentation
      Orange country convention center(米国)
    • Related Report
      2011 Final Research Report
  • [Presentation] Role of 11-17 Varies al Different Periods After Hemalopoietic Stem Cell Transplanlation : ProlectionFrom Acule GraIt-Versus-Host Disease and Exacerbation of Chronic Graft-Versus-Host Disease2010

    • Author(s)
      Rie Kuroda, Ryosei Nishimura, et al.
    • Organizer
      第52回アメリカ血液学会総会
    • Place of Presentation
      フロリダ州オーランド(アメリカ)
    • Related Report
      2010 Annual Research Report
  • [Presentation] Cytokine-Induced Killer Cells Facilitate lmmune Reconsttitution After Allogeneic BMT In Mice.2010

    • Author(s)
      Shintaro Mase, Ryosei Nishimura, et al
    • Organizer
      第52回アメリカ血液学会総会
    • Place of Presentation
      フロリダ州オーランド(アメリカ)
    • Related Report
      2010 Annual Research Report
  • [Presentation] Potent Strategy for Treatmet of Gvhd and Autoimmune-Diseased by Infusion of Donor-Typed or Even Third-Party Tolerogenic Dendritic Cells by Psoralen Plus UVA Treatment2010

    • Author(s)
      Hideaki Maeba, Ryosei Nishimura, et al.
    • Organizer
      第52回アメリカ血液学会総会
    • Place of Presentation
      フロリダ州オーランド(アメリカ)
    • Related Report
      2010 Annual Research Report
  • [Presentation] Expansion of Liver-lnfiltrating CTL CIone In Concert with the Development of Hepatitis-Associated AA.2010

    • Author(s)
      Yasuhiro Ikawa, Ryosei Nishimura, et al.
    • Organizer
      第52回アメリカ血液学会総会
    • Place of Presentation
      フロリダ州オーランド(アメリカ)
    • Related Report
      2010 Annual Research Report
  • [Presentation] Strong inhibition of alloreaction by newly gene rated tolerogenic dendritic cells by psora len plus UVA treatment2009

    • Author(s)
      Maeba H, Nishimura R
    • Organizer
      第51回米国血液学会
    • Place of Presentation
      New Orleans convention center(米国)
    • Year and Date
      2009-12-08
    • Related Report
      2011 Final Research Report
  • [Presentation] Strong inhibition of alloreaction by newly generated tolerogenic dendritoc cells by psoralen plus UVA treatment2009

    • Author(s)
      Hideaki Maeba
    • Organizer
      第51回米国血液学会
    • Place of Presentation
      ニューオリンズ (USA)
    • Year and Date
      2009-12-08
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi